UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Wt1 functions in ovarian follicle development by regulating granulosa cell differentiation

Human molecular genetics, 2014-01, Vol.23 (2), p.333-341

2014

Volltextzugriff (PDF)

Wilms tumor genetics: Mutations in WT1, WTX, and CTNNB1 account for only about one-third of tumors

Genes chromosomes & cancer, 2008-06, Vol.47 (6), p.461-470

2008

Volltextzugriff (PDF)

Children's Oncology Group's 2013 blueprint for research: Renal tumors

Pediatric blood & cancer, 2013-06, Vol.60 (6), p.994-1000

2013

Volltextzugriff (PDF)

Loss of Heterozygosity for Chromosomes 1p and 16q Is an Adverse Prognostic Factor in Favorable-Histology Wilms Tumor: A Report From the National Wilms Tumor Study Group

Journal of clinical oncology, 2005-10, Vol.23 (29), p.7312-7321

2005

Volltextzugriff (PDF)

WT1 Mutation and 11P15 Loss of Heterozygosity Predict Relapse in Very Low-Risk Wilms Tumors Treated With Surgery Alone: A Children's Oncology Group Study

Journal of clinical oncology, 2011-02, Vol.29 (6), p.698-703

2011

Volltextzugriff (PDF)

Ubiquitin specific protease 18 (Usp18) is a WT1 transcriptional target

Experimental cell research, 2013-03, Vol.319 (5), p.612-622

2013

Volltextzugriff (PDF)

Race Disparities in Peptide Profiles of North American and Kenyan Wilms Tumor Specimens

Journal of the American College of Surgeons, 2014-04, Vol.218 (4), p.707-720

2014

Volltextzugriff (PDF)

Twenty-four new cases of WT1 germline mutations and review of the literature: Genotype/phenotype correlations for Wilms tumor development

American journal of medical genetics, 2004-06, Vol.127A (3), p.249-257

2004

Volltextzugriff (PDF)

Treatment With Nephrectomy Only for Small, Stage I/Favorable Histology Wilms’ Tumor: A Report From the National Wilms’ Tumor Study Group

Journal of clinical oncology, 2001-09, Vol.19 (17), p.3719-3724

2001

Volltextzugriff (PDF)

Generation of a Wt1 conditional deletion, nuclear red fluorescent protein reporter allele in the mouse

Differentiation (London), 2024-07, Vol.138, p.100791, Article 100791

2024

Volltextzugriff (PDF)

Identification of germline DICER1 mutations and loss of heterozygosity in familial Wilms tumour

Journal of medical genetics, 2016-06, Vol.53 (6), p.385-388

2016

Volltextzugriff (PDF)

Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation

The Journal of clinical investigation, 2011-01, Vol.121 (1), p.174-183

2011

Volltextzugriff (PDF)

Wilms tumor 1 (WT1) regulates KRAS-driven oncogenesis and senescence in mouse and human models

The Journal of clinical investigation, 2010-11, Vol.120 (11), p.3940-3952

2010

Volltextzugriff (PDF)

Left-sided cryptorchidism in mice with Wilms' tumour 1 gene deletion in gubernaculum testis

The Journal of pathology, 2013-05, Vol.230 (1), p.39-47

2013

Volltextzugriff (PDF)

Identification of germline DICER1 mutations and loss of heterozygosity in familial Wilms tumor using whole genome sequencing

Journal of medical genetics, 2015-11, Vol.53 (6), p.385-388

2015

Volltextzugriff (PDF)

Hallmark discoveries in the biology of Wilms tumour

Nature reviews. Urology, 2024-03, Vol.21 (3), p.158-180

2024

Volltextzugriff (PDF)

Denys-Drash syndrome: Relating a clinical disorder to genetic alterations in the tumor suppressor gene WT1

The Journal of pediatrics, 1993-11, Vol.123 (5), p.673-678

1993

Volltextzugriff (PDF)

Long-term Outcomes for Infants With Very Low Risk Wilms Tumor Treated With Surgery Alone in National Wilms Tumor Study-5

Annals of surgery, 2010-03, Vol.251 (3), p.555-558

2010

Volltextzugriff (PDF)

Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group

Pediatric blood & cancer, 2008-02, Vol.50 (2), p.236-241

2008

Volltextzugriff (PDF)

Mediators of receptor tyrosine kinase activation in infantile fibrosarcoma: a Children's Oncology Group study

The Journal of pathology, 2012-09, Vol.228 (1), p.119-130

2012

Volltextzugriff (PDF)

Clinical outcome and biological predictors of relapse following nephrectomy only for very low risk Wilms tumor (VLR WT): A report from Children’s Oncology Group AREN0532

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.10023-10023

2015

Volltextzugriff (PDF)

Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: A report from the National Wilms Tumor Study Group

Pediatric blood & cancer, 2007-05, Vol.48 (5), p.493-499

2007

Volltextzugriff (PDF)

Reply to B. Royer-Pokora et al

Journal of clinical oncology, 2011-06, Vol.29 (16), p.e487-e488

2011

Volltextzugriff (PDF)

Bilateral gonadoblastoma with dysgerminoma and pilocytic astrocytoma with WT1 GT-IVS9 mutation: A 46 XY phenotypic female with Frasier syndrome

Pediatric blood & cancer, 2009-12, Vol.53 (7), p.1349-1351

2009

Volltextzugriff (PDF)

Upregulation of c-MYC in WT1-mutant tumors: assessment of WT1 putative transcriptional targets using cDNA microarray expression profiling of genetically defined Wilms' tumors

Oncogene, 2003-06, Vol.22 (24), p.3821-3826

2003

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Full Text

SpracheEnglisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(42)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Wt1 functions in ovarian follicle development by regulating granulosa cell differentiation

Wilms tumor genetics: Mutations in WT1, WTX, and CTNNB1 account for only about one-third of tumors

Children's Oncology Group's 2013 blueprint for research: Renal tumors

Loss of Heterozygosity for Chromosomes 1p and 16q Is an Adverse Prognostic Factor in Favorable-Histology Wilms Tumor: A Report From the National Wilms Tumor Study Group

WT1 Mutation and 11P15 Loss of Heterozygosity Predict Relapse in Very Low-Risk Wilms Tumors Treated With Surgery Alone: A Children's Oncology Group Study

Ubiquitin specific protease 18 (Usp18) is a WT1 transcriptional target

Race Disparities in Peptide Profiles of North American and Kenyan Wilms Tumor Specimens

Twenty-four new cases of WT1 germline mutations and review of the literature: Genotype/phenotype correlations for Wilms tumor development

Treatment With Nephrectomy Only for Small, Stage I/Favorable Histology Wilms’ Tumor: A Report From the National Wilms’ Tumor Study Group

Generation of a Wt1 conditional deletion, nuclear red fluorescent protein reporter allele in the mouse

Identification of germline DICER1 mutations and loss of heterozygosity in familial Wilms tumour

Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation

Wilms tumor 1 (WT1) regulates KRAS-driven oncogenesis and senescence in mouse and human models

Left-sided cryptorchidism in mice with Wilms' tumour 1 gene deletion in gubernaculum testis

Identification of germline DICER1 mutations and loss of heterozygosity in familial Wilms tumor using whole genome sequencing

Hallmark discoveries in the biology of Wilms tumour

Denys-Drash syndrome: Relating a clinical disorder to genetic alterations in the tumor suppressor gene WT1

Long-term Outcomes for Infants With Very Low Risk Wilms Tumor Treated With Surgery Alone in National Wilms Tumor Study-5

Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group

Mediators of receptor tyrosine kinase activation in infantile fibrosarcoma: a Children's Oncology Group study

Clinical outcome and biological predictors of relapse following nephrectomy only for very low risk Wilms tumor (VLR WT): A report from Children’s Oncology Group AREN0532

Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: A report from the National Wilms Tumor Study Group

Reply to B. Royer-Pokora et al

Bilateral gonadoblastoma with dysgerminoma and pilocytic astrocytoma with WT1 GT-IVS9 mutation: A 46 XY phenotypic female with Frasier syndrome

Upregulation of c-MYC in WT1-mutant tumors: assessment of WT1 putative transcriptional targets using cDNA microarray expression profiling of genetically defined Wilms' tumors

Aktive Filter

Suchergebnisse filtern